# Trade Mark Journal No.2025/042 17 October 2025

## WO0000001878716 (5,42,44)

Office of origin: United States of America

Date of International Registration:21 August 2025
Date of designation in the UK: 21 August 2025

International priority date claimed: 12 May 2025 (United States of America) (99181024)

Class 5
  Pharmaceutical preparations for the treatment and prevention of rare and orphan diseases and disorders; pharmaceutical preparations for the treatment and prevention of hematological diseases and disorders; pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; pharmaceutical preparations for the treatment and prevention of genetic diseases and disorders; pharmaceutical preparations for the treatment and prevention of hereditary angioedema (HAE); pharmaceutical preparations for the treatment and prevention of bradykinin mediated angioedema; pharmaceutical preparations for the treatment and prevention of acquired angioedema.
Class 42
  Providing medical and scientific research information.
Class 44
  Providing medical information; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals.

Pharvaris GmbH

Representative: Makiko Coffland Christensen O'Connor Johnson Kindness, 1201 Third Avenue, Suite 3600, Seattle WA 98101, UNITED STATES OF AMERICA